QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (58) Citing Articles via Google Scholar Google Scholar Articles by Bradley, S. R. Articles by Conn, P. J. Search for Related Content PubMed PubMed Citation Articles by Bradley, S. R. Articles by Conn, P. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB GLUTAMIC ACID HYDROCHLORIDE HALOPERIDOL

 Previous Article  |  Next Article 

The Journal of Neuroscience, May 1, 2000, 20(9):3085-3094

Activation of Group II Metabotropic Glutamate Receptors Inhibits Synaptic Excitation of the Substantia Nigra Pars Reticulata

Stefania Risso Bradley¹, Michael J. Marino¹, Marion Wittmann³, Susan T. Rouse¹, Hazar Awad¹, Allan I. Levey², and P. Jeffrey Conn¹

Departments of ¹ Pharmacology and ² Neurology, Emory University, Atlanta, Georgia 30322, and ³ Tierphysiologie, University of Tuebingen, D-72076 Tuebingen, Germany

Loss of nigrostriatal dopaminergic neurons in Parkinson's disease (PD) leads to increased activity of glutamatergic neurons in the subthalamic nucleus (STN). Recent studies reveal that the resultant increase in STN-induced excitation of basal ganglia output nuclei is responsible for the disabling motor impairment characteristic of PD. On the basis of this, it is possible that any manipulation that reduces activity at excitatory STN synapses onto basal ganglia output nuclei could be useful in the treatment of PD. We now report that group II metabotropic glutamate receptors (mGluRs) are presynaptically localized on STN terminals and that activation of these receptors inhibits excitatory transmission at STN synapses. In agreement with the hypothesis that this could provide a therapeutic benefit in PD, a selective agonist of group II mGluRs induces a dramatic reversal of catalepsy in a rat model of PD. These results raise the exciting possibility that selective agonists of group II mGluRs could provide an entirely new approach to the treatment of PD. These novel therapeutic agents would provide a noninvasive pharmacological treatment that does not involve the manipulation of dopaminergic systems, thus avoiding the problems associated with current therapies.

Key words: substantia nigra pars reticulata; subthalamic nucleus; group II metabotropic glutamate receptors; Parkinson's disease; catalepsy; presynaptic inhibition

---

Copyright © 2000 Society for Neuroscience  0270-6474/00/2093085-10$05.00/0

This article has been cited by other articles:

				L. Ohana, O. Barchad, I. Parnas, and H. Parnas The Metabotropic Glutamate G-protein-coupled Receptors mGluR3 and mGluR1a Are Voltage-sensitive J. Biol. Chem., August 25, 2006; 281(34): 24204 - 24215. [Abstract] [Full Text] [PDF]

				K.-Z. Shen and S. W. Johnson Subthalamic stimulation evokes complex EPSCs in the rat substantia nigra pars reticulata in vitro J. Physiol., June 15, 2006; 573(3): 697 - 709. [Abstract] [Full Text] [PDF]

				M. J. Marino, D. L. Williams Jr., J. A. O'Brien, O. Valenti, T. P. McDonald, M. K. Clements, R. Wang, A. G. DiLella, J. F. Hess, G. G. Kinney, et al. Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment PNAS, November 11, 2003; 100(23): 13668 - 13673. [Abstract] [Full Text] [PDF]

				O. V. Poisik, G. Mannaioni, S. Traynelis, Y. Smith, and P. J. Conn Distinct Functional Roles of the Metabotropic Glutamate Receptors 1 and 5 in the Rat Globus Pallidus J. Neurosci., January 1, 2003; 23(1): 122 - 130. [Abstract] [Full Text] [PDF]

				H. Parnas, J.-C. Valle-Lisboa, and L. A. Segel Can the Ca2+ hypothesis and the Ca2+-voltage hypothesis for neurotransmitter release be reconciled? PNAS, December 24, 2002; 99(26): 17149 - 17154. [Abstract] [Full Text] [PDF]

				M. Wittmann, M. J. Marino, and P. J. Conn Dopamine Modulates the Function of Group II and Group III Metabotropic Glutamate Receptors in the Substantia Nigra Pars Reticulata J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 433 - 441. [Abstract] [Full Text] [PDF]

				W. S. Cobb and E. D. Abercrombie Distinct Roles for Nigral GABA and Glutamate Receptors in the Regulation of Dendritic Dopamine Release under Normal Conditions and in Response to Systemic Haloperidol J. Neurosci., February 15, 2002; 22(4): 1407 - 1413. [Abstract] [Full Text] [PDF]

				M. J. Marino, M. Wittmann, S. R. Bradley, G. W. Hubert, Y. Smith, and P. J. Conn Activation of Group I Metabotropic Glutamate Receptors Produces a Direct Excitation and Disinhibition of GABAergic Projection Neurons in the Substantia Nigra Pars Reticulata J. Neurosci., September 15, 2001; 21(18): 7001 - 7012. [Abstract] [Full Text] [PDF]

				M. Wittmann, M. J. Marino, S. R. Bradley, and P. J. Conn Activation of Group III mGluRs Inhibits GABAergic and Glutamatergic Transmission in the Substantia Nigra Pars Reticulata J Neurophysiol, May 1, 2001; 85(5): 1960 - 1968. [Abstract] [Full Text] [PDF]

				H. Awad, G. W. Hubert, Y. Smith, A. I. Levey, and P. J. Conn Activation of Metabotropic Glutamate Receptor 5 Has Direct Excitatory Effects and Potentiates NMDA Receptor Currents in Neurons of the Subthalamic Nucleus J. Neurosci., November 1, 2000; 20(21): 7871 - 7879. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help